Patient Evidence Guide – Updated August 2026
Do Supplements or CBD Help Endometriosis? What the Evidence Actually Shows
A patient-centered review of melatonin, vitamin D, omega-3, NAC, curcumin, probiotics, CBD, cannabis, and supplement safety.
Medically reviewed by Andrea Vidali, MD – Endometriosis Surgical Specialists International (ESSI).
Evidence you can trust: this guide draws on systematic reviews and high-quality trials, grades findings by certainty of evidence, and focuses on pain relief rather than promising a disease cure.
The 60-Second Answer
No supplement has been established as a disease-modifying treatment for endometriosis, a reliable fertility treatment, or a consistently effective treatment for endometriosis pain. Some products may still have a rational, narrower role: treating a documented deficiency, improving sleep, supporting general nutrition, or helping a specific coexisting symptom. CBD is widely used, but the strongest 2026 placebo-controlled trial found that CBD-enriched oil did not reduce pain better than placebo.
Why Supplements Are So Popular in Endometriosis
People with endometriosis frequently try supplements because their pain is real, treatment can be incomplete, and online claims often sound biologically convincing. Antioxidants may affect oxidative stress. Omega-3 fats may influence inflammatory mediators. Melatonin may influence sleep and pain processing. Cannabinoids interact with pain-signaling pathways.
But a plausible mechanism is only the beginning. The central clinical question is whether a product produces a meaningful benefit in patients when compared with placebo, whether the result is independently replicated, and whether the dose and product are safe.
ESSI’s position is neither to dismiss patients nor to promote unproven products. The goal is to separate treatment of endometriosis from treatment of a deficiency or associated symptom, and to make supplement use safer when patients choose it.
The most important distinction: treating endometriosis versus supporting health
A supplement can be medically appropriate without being an endometriosis treatment. Iron should be used when iron deficiency is confirmed. Vitamin D should be replaced when levels are low or bone health requires it. Melatonin may be reasonable when insomnia is a major problem. These are legitimate clinical goals, but they do not prove that the supplement shrinks lesions, prevents recurrence, restores fertility, or reliably controls endometriosis pain.
| Category | Examples | What This Category Means |
|---|---|---|
| Treat a documented need | Iron deficiency; vitamin D deficiency; other confirmed nutritional deficits | Appropriate medical care, but not a treatment for endometriosis itself |
| Possible symptom support | Melatonin for sleep; selected dietary approaches; individualized adjunctive use | Low-certainty evidence. Discuss goals, dose, and duration with a clinician |
| Not established | NAC; curcumin/resveratrol; probiotics; magnesium/zinc/PEA; CBD for pain | Mechanisms or early studies exist, but reliable clinical efficacy has not been established |
| Use extra caution | High-dose EGCG; high-dose vitamin E; St John’s wort; unverified blends; THC in pregnancy or driving | Interactions, liver toxicity, bleeding risk, contamination, or impairment may matter |
What the Highest-Level Evidence Shows
A 2025 systematic review restricted to randomized, double-blind, placebo-controlled supplement trials found no reliable overall benefit across pelvic pain, dysmenorrhea, dyspareunia, or quality of life. However, the studies were small and highly heterogeneous, and very different products were pooled together. The correct conclusion is not that every supplement has been proven ineffective; it is that no individual supplement currently has enough high-certainty, reproducible evidence for routine use.
A broader 2025 antioxidant meta-analysis reported possible benefit for selected outcomes, especially melatonin and dysmenorrhea. Those findings remain low certainty because of small studies, variation in trial design, risk-of-bias concerns, and lack of independent replication. Current guidance is therefore nuanced: no major guideline recognizes a supplement as an established treatment, while the March 2026 Australian Living Guideline conditionally recommends discussing fish oil and vitamin D with patients while clearly explaining that evidence of benefit is limited.
Why “promising” does not always mean “proven”
Most endometriosis supplement claims stop before the final two steps of the evidence ladder below.
- Biologically plausible: A supplement affects inflammation, oxidative stress, hormones, nerves, or blood vessels in a laboratory model.
- Animal or cell data: A compound changes lesion behavior in a dish or in rodents. Useful for hypotheses, not proof in patients.
- Small human study: Participants may improve, but natural symptom variation, regression to the mean, co-treatments, and expectation effects can mislead.
- Placebo-controlled trial: The supplement must outperform a matched placebo on outcomes that matter to patients.
- Replication and guidelines: Results should be independently reproduced, clinically meaningful, safe, and applicable to real patients.
Most endometriosis supplement claims stop before steps 4 and 5.
Supplement-by-Supplement Guide
At a glance
| Supplement | Best Current Signal | What It Has Not Shown | ESSI Bottom Line |
|---|---|---|---|
| Melatonin | Possible help for sleep and selected dysmenorrhea outcomes | Reliable lesion regression, fertility benefit, or consistent pain relief | Reasonable only for a defined symptom goal; evidence remains low certainty |
| Vitamin D | Corrects deficiency and supports bone health | Consistent endometriosis pain or IVF benefit | Test and replace deficiency; do not market as an endometriosis treatment |
| Omega-3 | Food-based intake is nutritionally reasonable | Capsules reliably outperform placebo for endometriosis pain | Food first; capsule benefit remains uncertain |
| NAC | Strong mechanism; preliminary studies | Replicated placebo-superior pain or lesion benefit | Not established; avoid presenting as a proven lesion-shrinking therapy |
| Curcumin / resveratrol | Anti-inflammatory laboratory effects | Reliable monotherapy benefit in patients | Bioavailability and study quality remain major limitations |
| Probiotics | Possible short-term symptom signal in small trials | Durable, endometriosis-specific efficacy | May help selected bowel symptoms, but not proven to treat endometriosis |
| CBD | Many patient reports; plausible pain biology | Pain benefit over placebo in the 2026 randomized controlled trial | Not an established endometriosis analgesic |
Full guide by product
| Product | What May Be Reasonable | What Has Not Been Shown | ESSI Position |
|---|---|---|---|
| Melatonin | Possible signal for sleep and selected dysmenorrhea outcomes; trials are mixed | No reliable evidence of lesion regression, fertility improvement, or consistent pain control | May be reasonable for a defined sleep goal after reviewing sedation and interactions |
| Vitamin D | Important for deficiency correction and bone health | Most endometriosis pain trials are negative; no established IVF benefit | Measure or assess risk, then replace deficiency, not endometriosis |
| Omega-3 fatty acids | Nutritionally reasonable as part of a food-based diet; inflammatory biomarkers may change | Placebo-controlled capsule trials have not shown dependable pain relief | Food first. Capsules should not be presented as proven treatment |
| Vitamins C and E | Some small trials report selected pain improvements | Signals are fragile, inconsistent, and sensitive to study quality; high-dose vitamin E may increase bleeding risk | Not routinely recommended as endometriosis therapy |
| N-acetylcysteine (NAC) | Strong biological rationale and encouraging uncontrolled reports | No replicated placebo-superior evidence for pain, lesion shrinkage, or fertility | Promising is not proven; avoid claims that it reliably shrinks endometriomas |
| Curcumin / resveratrol | Anti-inflammatory and anti-angiogenic activity in laboratory models | Standard oral formulations have not shown reliable monotherapy benefit in patients | Bioavailability and trial quality remain important limitations |
| Probiotics | Two small trials suggest possible short-lived symptom effects | No durable, replicated endometriosis-specific efficacy | Consider only for an individualized gastrointestinal goal, not as disease treatment |
| Magnesium / zinc / selenium / PEA | Each has a rationale or limited signal in selected studies | Evidence is absent, single-study, conflicting, or not independently replicated | Do not use empirically at high doses; correct documented nutritional needs |
| EGCG / green tea extract | Strong preclinical anti-angiogenic interest | No adequate endometriosis randomized controlled trial evidence | High-dose extracts can injure the liver; brewed tea is not equivalent to concentrated extract |
CBD and Cannabis
CBD, THC-containing cannabis, mixed CBD/THC preparations, inhaled cannabis, oral oils, gummies, and topical products should not be grouped as though they are one treatment. Purified or CBD-enriched products are generally non-intoxicating, while THC can impair cognition, reaction time, and driving, and carries different reproductive, psychiatric, and dependency concerns.
What the 2026 randomized CBD trial found
The DREAMLAND study randomized 102 patients with surgically confirmed endometriosis and recurrent postoperative pain to CBD-enriched oil or placebo for ten weeks while they continued hormonal therapy. CBD did not outperform placebo on the primary pain outcome, and mild adverse effects were more frequent with CBD, although no serious adverse events were reported.
| Outcome | CBD-Enriched Oil | Placebo |
|---|---|---|
| Achieved at least 50 percent pain reduction | About 40 percent of patients | About 40 percent of patients |
| Achieved at least 30 percent pain reduction | About 60 percent of patients | About 60 percent of patients |
Bottom line: CBD did not outperform placebo for pain. Mild adverse effects were more frequent with CBD; no serious adverse events were reported.
This does not prove that no patient can ever feel better with CBD. It does mean that CBD should not be presented as an established endometriosis analgesic. Observational cannabis studies report perceived improvements in pain, sleep, nausea, and reduced analgesic use, but they are vulnerable to selection bias, variable products, dose differences, and expectation effects. No cannabinoid has been shown to shrink endometriosis lesions or improve fertility.
Why Patients May Genuinely Feel Better Even When a Trial Is Negative
Natural symptom fluctuation: Endometriosis pain varies across cycles and over time. People often start a new intervention during a severe flare, after which symptoms may naturally move toward their usual level.
Sleep and stress effects: A product may improve sleep, anxiety, nausea, or general wellbeing without directly changing endometriosis biology.
Simultaneous changes: Starting a supplement often coincides with diet changes, exercise, pelvic-floor therapy, hormonal treatment, surgery recovery, or reduced alcohol use.
Expectation and contextual care: Attention, hope, treatment rituals, and clinician support can produce meaningful symptom improvement. That improvement is real, even when it is not caused by the supplement’s specific pharmacology.
The placebo comparison: A placebo-controlled trial asks whether the active product adds benefit beyond these background effects. A large improvement in both groups can coexist with a negative trial.
Safety and Drug Interactions
“Natural” does not mean inert. Concentrated green tea extract can cause liver injury. High-dose vitamin E and some herbal products may increase perioperative bleeding. St John’s wort can reduce hormonal contraceptive effectiveness. CBD can cause sedation, diarrhea, appetite or weight changes, and drug interactions; THC can impair driving and cognition. Product labeling may be inaccurate, and multi-ingredient blends can make it impossible to know which dose caused benefit or harm.
Before you start a supplement or cannabinoid
| Check | Why It Matters |
|---|---|
| Tell your clinician everything you take | Include gummies, teas, powders, oils, “detox” products, and multi-ingredient blends |
| Check pregnancy and fertility plans | Safety data are often limited. THC and systemic cannabinoids should be approached cautiously |
| Review medication interactions | Hormonal contraception, anticoagulants, NSAIDs, sedatives, seizure medicines, and other drugs may interact |
| Plan for surgery | High-dose vitamin E, garlic, ginkgo, cannabinoids, and other products may affect bleeding, sedation, or anesthesia |
| Avoid concentrated high-dose EGCG | Green tea extract can injure the liver, especially at high supplemental doses or when taken fasting |
| Choose verified products | Prefer independent quality testing and avoid proprietary blends that hide individual doses |
ESSI’s Practical Decision Framework
1. Define the goal
Pain? Sleep? Bowel symptoms? Deficiency? Fertility? A supplement should have one clearly stated target.
2. Check whether the target has evidence
Use human placebo-controlled evidence when available, not laboratory mechanisms alone.
3. Establish a baseline
Record symptom scores, sleep quality, bowel function, and relevant laboratory values before starting.
4. Use a time-limited trial
Agree on a dose, duration, and stopping rule. Do not continue indefinitely because of sunk cost.
5. Avoid replacing effective care
Supplements should not delay appropriate imaging, specialist assessment, hormonal treatment, pain care, fertility planning, or surgery when indicated.
6. Reassess honestly
Continue only when benefit is meaningful, reproducible, and greater than cost or harm.
Frequently Asked Questions
Can supplements cure endometriosis?
No. No supplement has been proven to eradicate lesions, prevent recurrence, or cure endometriosis.
Can NAC shrink an endometrioma?
An influential nonrandomized study reported shrinkage, but the result has not been confirmed in a robust placebo-controlled trial. NAC should not be described as a proven lesion-shrinking treatment.
Should everyone with endometriosis take vitamin D?
No. Vitamin D is important when deficiency, low intake, limited sun exposure, bone risk, or another clinical indication exists. Routine use specifically to treat endometriosis is not supported.
Is melatonin the best-supported supplement?
Melatonin has the clearest low-certainty signal, especially for sleep and selected dysmenorrhea outcomes, but trials are mixed and it is not a disease-modifying treatment.
Does CBD help endometriosis pain?
In the strongest 2026 randomized trial, CBD-enriched oil did not reduce pain better than placebo. Some individuals report benefit, but CBD is not an established endometriosis analgesic.
Is medical cannabis different from CBD?
Yes. THC-containing products can be intoxicating and have different risks. Evidence for endometriosis remains largely observational.
Are food changes more useful than pills?
A balanced food-first approach may support overall health and can help selected bowel symptoms. Evidence that a specific diet treats endometriosis itself remains limited.
What should I stop before surgery?
The answer depends on the product, dose, and anesthetic plan. Provide your complete list to the surgical team; do not decide based only on an internet list.
The ESSI Perspective
Patients should not be blamed for looking for additional relief. The supplement market grew because conventional care often failed to provide timely diagnosis, complete pain relief, or trusted explanations. Our responsibility is to be equally honest in both directions: not to dismiss a patient’s experience, and not to turn a plausible mechanism into a promise. Treat deficiencies. Target associated symptoms. Protect patients from interactions and unsafe products. But do not allow supplements or cannabinoids to substitute for a complete evaluation and an individualized endometriosis treatment plan.
Medical disclaimer: This article is educational content only. It does not establish an individual diagnosis or treatment recommendation and should not replace personalized medical advice. Speak with a qualified clinician about your individual situation and before starting, stopping, or changing any supplement, cannabinoid, or medication.
References and Evidence Sources
- Salmeri N, et al. Dietary Supplements for Endometriosis-Associated Pain: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Gynecol Obstet Invest. 2025;91:101-114.
- Esmaeilzadeh S, et al. Efficacy of antioxidant supplementation in alleviating endometriosis-related pain: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2025;23:164.
- RANZCOG. Australian Living Evidence Guideline: Endometriosis. Living update, March 2026. Recommendation 55.
- NICE. Endometriosis: diagnosis and management (NG73). Updated 2024.
- Becker CM, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022.
- Nodler JL, et al. Supplementation with vitamin D or omega-3 fatty acids in adolescent girls and young women with endometriosis (SAGE). Am J Clin Nutr. 2020;112:229-236.
- Soderman L, et al. Melatonin for endometriosis-associated pain: a randomized double-blind placebo-controlled trial. PLoS One. 2023;18:e0286182.
- Schwertner A, et al. Efficacy of melatonin in the treatment of endometriosis: a phase II randomized double-blind placebo-controlled trial. Pain. 2013;154:874-881.
- Mendes da Silva D, et al. Resveratrol and oral contraceptive for treatment of endometriosis-associated pain: a randomized clinical trial. J Endocr Soc. 2017;1:359-369.
- Abokhrais IM, et al. A pilot double-blind randomized placebo-controlled trial of omega-3 polyunsaturated fatty acids in endometriosis. PLoS One. 2020;15:e0227695.
- Watrowski R, et al. N-Acetylcysteine in Endometriosis: A Systematic Review of Biological Rationale and Clinical Evidence. Antioxidants. 2026;15:880.
- CBD DREAMLAND Study investigators. Cannabidiol-Enriched Extract Oil for Postoperative Management of Chronic Pelvic Pain Secondary to Endometriosis: A Randomized Clinical Trial. 2026. DOI: 10.1177/25785125251413989.
- EFSA Panel. Scientific opinion on the safety of green tea catechins. EFSA Journal. 2018;16:5239.
- NIH LiverTox. Green Tea. NCBI Bookshelf.
- Berry-Bibee EN, et al. St John’s wort and hormonal contraceptives: a systematic review. Contraception. 2016;94:668-677.
